Nasha Winters, ND - Using LDN to Quell the Over-Reactive Autoimmune Conditions Triggered by Many of Today's Cancer Drugs (2019 Conference) (LDN, low dose naltrexone)

 


Dr Akbar Khan's LDN 2019 Conference Presentation

Low Dose Naltrexone (LDN) vs. Chemotherapy: One “Unproven” Therapy Against Another?

Terry Wingo - LDN Specialist, LDN Radio Show 20 April 2021 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Terry Wingo graduated from Auburn University in 1975 with a bachelor of science in Pharmacy. He has fellowships with the American College of Apothecaries and the American College of Veterinary Pharmacists.

 

Tara Thompson, PharmD - Compounding 101: The Basics of Compounding with Naltrexone (2019 Conference) (LDN, low dose naltrexone)

Tara Thompson, PharmD discusses the purpose of a compounding pharmacy, how to choose one, the benefits and limitations of compounding, and dosage forms. She give an overview of naltrexone, dosing of LDN in various conditions, and how to write a prescription for compounded naltrexone.

 

LDN 2019 Conference - Sunday Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

 

Stephen Dickson, BSC (hons) MRPharmS - Mechanism of Action of Low Dose Naltrexone (2019 Conference) (LDN, low dose naltrexone)

 

Sarah Zielsdorf, MD, MS - "Just try LDN": 3 years of insight from over 1000 patients' use of Low Dose Naltrexone (2019 Conference) (LDN, low dose naltrexone)

 

Michelle Moser, RPh - Making a difference (2019 Conference) (LDN, low dose naltrexone)

Michelle Moser, RPh discusses the pharmacist’s role in LDN, including information resources for prescribers and customers, and facilitators between the customers and their treatments. She presents an LDN Patient Care Model.